Exousia Bio, Inc.
Exousia Bio, Inc. is a development-stage U.S. company focused on building an eLearning and gaming platform that teaches children financial literacy and resource management. Its core concept is the twoplus1® educational game, which is intended to combine subscription access with in-game monetization features such as virtual property trading commissions.
Fiscal year 2025 · change from previous year
Development 2023–2025
Business
Share of revenueInteractive game-based learning products designed to teach children financial knowledge and resource management.
Recurring access to the twoplus1® platform and its educational content.
In-game trading and transaction features intended to generate commissions.
Customers
The company appears to sell primarily to families and children through a consumer-facing digital learning product, with value driven by education and entertainment in one platform. Its offering is also relevant to parents and guardians who want structured financial education for children, and potentially to schools or other educational users if the platform is later distributed through institutional channels.
Buy or use the game for interactive lessons in finance, property, and resource management.
Support purchases because the product combines entertainment with educational value.
Potential future buyers of the platform for classroom or enrichment use.
Strategy
The company’s strategy is to enter the eLearning and gaming markets with a niche product that teaches financial literacy to children. Management also emphasizes low startup costs, technology-enabled delivery, and future monetization through subscriptions and transaction commissions, but the business remains dependent on raising capital to fund development and marketing.
The company needs a marketable product before it can generate meaningful revenue.
The company has limited cash and a going-concern risk, so external capital is required to continue development.
Trademark protection supports brand recognition and reduces imitation risk as the product expands.
Geography
Exousia Bio is incorporated in Wyoming and operates as a U.S.-based startup, but the reports also note trademark protection for twoplus1® in the United Kingdom and plans to expand protection into other key regions. No country-level revenue disclosure is provided, so the business appears to be at an early commercialization stage with limited geographic footprint today.
Risks
The company is a development-stage business with minimal revenue, limited operations, and an auditor-issued going-concern warning, so financing risk is central to the investment case. Execution risk is also high because the business must build, market, and monetize a new educational game while competing for attention in crowded eLearning and gaming markets.
The company has limited operations, minimal cash, and an auditor warning about its ability to continue.
Operations are expected to be funded through additional equity or debt issuances.
Exposure: Dilution or unfavorable financing terms could pressure shareholders.
Revenue depends on launching and monetizing a new educational game and subscription platform.
Exposure: Delayed launch or weak adoption would limit revenue generation.
The company plans to rely on cloud providers and consultants while handling customer and partner data.
Exposure: Security incidents could disrupt operations or damage trust.
Accounting
Judgemental itemsAuditors included an explanatory paragraph citing substantial doubt about continuation.
Impact: Affects confidence in asset realization, liability settlement, and future operations
Limited operations mean reported results depend heavily on judgment and assumptions.
Impact: Can materially affect expenses, liabilities, and any future revenue recognition
Future subscription and commission revenue will require careful timing and policy application.
Impact: Could affect reported revenue if services are delivered over time or transaction-based
Similar listed companies
Publicly listed companies with a comparable business focus.
eXoZymes Inc
EXOZ · Biological Products, (No Diagnostic Substances)
Exceed World, Inc.
EXDW · Services-Educational Services
Exicure, Inc
XCUR · Pharmaceutical Preparations
Duolingo, Inc.
DUOL · Services-Prepackaged Software
Superstar Platforms Inc.
SPST · Services-Business Services, NEC
Generation Bio Co.
Pharmaceutical Preparations
Last updated: 28/04/2026